Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnamon for CP/CPPS
NCT03946163Phase 1Completed
- Sponsor
- Al-Kindy College of Medicine
- Start
- Feb 2018
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (2 arms), sponsored by Al-Kindy College of Medicine. Primary endpoint: Positive response (Reduction of NIH-CPSI score by ≥ 6 points) at 1 month. Started Feb 2018; status: completed.
Beyond the preview
Go deeper on NCT03946163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03946163.